Apellis Pharmaceuticals, Inc.
APLSDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted in 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Apellis Pharmaceuticals, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
APLS is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 324
- +49 vs. Q4 2025
- Shares held
- 140.4M
- +25.8M (+22.6%) vs. Q4 2025
- Total value
- $5.56B
- +$2.69B (+93.5%) vs. Q4 2025
- New holders
- 127
- 91 more added
- Sold out
- 78
- 72 more reduced
5 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $10.2K |
| Q1 2026 | 324 | $5.56B |
| Q4 2025 | 280 | $3.17B |
| Q3 2025 | 273 | $2.77B |
| Q2 2025 | 247 | $2.29B |
| Q1 2025 | 255 | $2.80B |
| Q4 2024 | 260 | $4.05B |
| Q3 2024 | 265 | $3.52B |
| Q2 2024 | 263 | $4.56B |
| Q1 2024 | 302 | $6.97B |
| Q4 2023 | 284 | $7.16B |
| Q3 2023 | 256 | $4.34B |
| Q2 2023 | 317 | $9.81B |
| Q1 2023 | 282 | $7.49B |
| Q4 2022 | 244 | $5.26B |
| Q3 2022 | 250 | $6.67B |
| Q2 2022 | 212 | $4.15B |
| Q1 2022 | 212 | $4.62B |
| Q4 2021 | 187 | $3.91B |
| Q3 2021 | 181 | $2.29B |
| Q2 2021 | 205 | $4.13B |
| Q1 2021 | 175 | $2.80B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Hudson Bay Capital Management LP | 1,190,416 | $47.9M | 0.29% | +10,588+0.9% | Added |
| Bank of America Corp | 1,190,864 | $47.9M | 0.00% | +234,091+24.5% | Added |
| Healthcare of Ontario Pension Plan Trust Fund | 1,202,100 | $48.4M | 0.08% | +1,202,100 | New |
| Toronto Dominion Bank | 1,236,436 | $49.7M | 0.10% | +1,236,436 | New |
| TIG Advisors, LLC | 1,252,986 | $50.4M | 2.41% | +1,252,986 | New |
| Glazer Capital, LLC | 1,294,196 | $52.1M | 1.11% | +1,294,196 | New |
| Dimensional Fund Advisors LP | 1,338,995 | $53.7M | 0.01% | +1,158,070+640.1% | Added |
| Balyasny Asset Management LLC | 1,917,501 | $77.1M | 0.15% | +1,852,368+2,844.0% | Added |
| Goldman Sachs Group Inc | 1,980,144 | $79.7M | 0.01% | +1,790,939+946.6% | Added |
| Geode Capital Management, LLC | 2,075,075 | $83.5M | 0.01% | +49,406+2.4% | Added |
| Millennium Management LLC | 2,256,802 | $90.8M | 0.07% | +1,310,343+138.4% | Added |
| Suvretta Capital Management, LLC | 3,518,471 | $141.5M | 3.84% | −620,955−15.0% | Reduced |
| HBK Investments L P | 3,550,000 | $142.8M | 1.80% | +3,550,000 | New |
| RTW Investments, LP | 3,685,045 | $148.2M | 1.48% | −3,981,719−51.9% | Reduced |
| Point72 Asset Management, L.P. | 4,183,918 | $168.3M | 0.29% | +3,586,246+600.0% | Added |
| Deep Track Capital, LP | 4,532,374 | $182.3M | 3.76% | −3,217,626−41.5% | Reduced |
| Vanguard Capital Management LLC | 4,768,944 | $191.9M | 0.00% | +4,768,944 | New |
| Pentwater Capital Management LP | 5,250,000 | $211.2M | 1.50% | +5,250,000 | New |
| Vanguard Portfolio Management LLC | 5,404,559 | $217.4M | 0.01% | +5,404,559 | New |
| UBS Group AG | 6,206,681 | $249.7M | 0.04% | +2,020,459+48.3% | Added |
| State Street Corp | 6,844,990 | $275.4M | 0.01% | +2,231,544+48.4% | Added |
| Morgan Stanley | 10,042,399 | $404.0M | 0.02% | +869,395+9.5% | Added |
| Avoro Capital Advisors LLC | 12,222,222 | $491.7M | 4.84% | 00.0% | Unchanged |
| BlackRock, Inc. | 13,536,964 | $544.6M | 0.01% | +7,276,851+116.2% | Added |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −106−100.0% | Sold out |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −3,706,510−100.0% | Sold out |
| Siren, L.L.C. | 0 | $0 | 0.00% | −2,578,396−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −2,429,868−100.0% | Sold out |
| Jennison Associates LLC | 0 | $0 | 0.00% | −1,504,299−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −1,070,141−100.0% | Sold out |
| Simplify Asset Management Inc. | 0 | $0 | 0.00% | −538,008−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −461,186−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −374,450−100.0% | Sold out |
| Schroder Investment Management Group | 0 | $0 | 0.00% | −329,134−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −285,992−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −257,268−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −254,563−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −192,488−100.0% | Sold out |
| Apis Capital Advisors, LLC | 0 | $0 | 0.00% | −192,000−100.0% | Sold out |
| Silvercrest Asset Management Group LLC | 0 | $0 | 0.00% | −190,759−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −186,328−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −150,776−100.0% | Sold out |
| DekaBank Deutsche Girozentrale | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| ING Groep NV | 0 | $0 | 0.00% | −139,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −110,900−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −109,733−100.0% | Sold out |
| Edgestream Partners, L.P. | 0 | $0 | 0.00% | −97,443−100.0% | Sold out |
| Coppell Advisory Solutions LLC | 0 | $0 | 0.00% | −77,390−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −71,747−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −50,114−100.0% | Sold out |
| Ishara Investments LP | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −42,134−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −34,039−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −31,091−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −25,500−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −24,075−100.0% | Sold out |
| Cerity Partners LLC | 0 | $0 | 0.00% | −23,971−100.0% | Sold out |
| Entropy Technologies, LP | 0 | $0 | 0.00% | −23,128−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −21,866−100.0% | Sold out |
| Diversified Trust Co | 0 | $0 | 0.00% | −18,942−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −18,843−100.0% | Sold out |
| Advent Capital Management | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −17,000−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −16,117−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −14,570−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −14,200−100.0% | Sold out |
| Pallas Capital Advisors LLC | 0 | $0 | 0.00% | −13,885−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −13,152−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −12,537−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −11,741−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −11,326−100.0% | Sold out |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −10,806−100.0% | Sold out |
| Perbak Capital Partners LLP | 0 | $0 | 0.00% | −10,217−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −9,302−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −9,078−100.0% | Sold out |
| Quantitative Investment Management, LLC | 0 | $0 | 0.00% | −8,611−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −4,210−100.0% | Sold out |
| Atlantic Private Wealth, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| EFG International AG | 0 | $0 | 0.00% | −788−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −643−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −369−100.0% | Sold out |
| Bessemer Group Inc | 0 | $0 | 0.00% | −205−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −189−100.0% | Sold out |
| ZRC Wealth Management, LLC | 0 | $0 | 0.00% | −151−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Sunbelt Securities, Inc. | 0 | $0 | 0.00% | −39−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −35−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Turning Point Benefit Group, Inc. | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Bare Financial Services, Inc | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| United Financial Planning Group LLC | 0 | $0 | 0.00% | −24−100.0% | Sold out |
| Greenline Wealth Management LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| South State Corp. | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |